10 Best Biotech Stocks to Buy Under $10
The head biotech analyst at Goldman Sachs, Salveen Richter, appeared on CNBC's "Squawk Box" on July 25 to discuss various topics, including the current status of the biotech industry and what to expect...
Ardelyx Inc. (ARDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 11,663,229 | $45,719,858 | +81% | 0.02% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 11,250,652 | $44,102,556 | +35% | 0.05% |
| 3. | D E Shaw D. E. Shaw | 2,458,666 | $9,637,971 | +29% | 0.01% |
| 4. | AQR Capital Management Cliff Asness | 2,312,363 | $9,064,463 | +47% | 0.01% |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 2,286,273 | $8,962,190 | +43% | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.63 | 200,000 | $725,880.00 | 2,896,871 | 2025-06-16 | Filing | |
| $3.69 | 200,000 | $737,260.00 | 2,696,871 | 2025-06-09 | Filing | |
| $3.29 | 100,000 | $329,120.00 | 2,496,871 | 2025-05-15 | Filing | |
| $4.22 | 381,377 | $1,610,936.45 | 2,396,871 | 2025-05-02 | Filing | |
| $5.00 | 77,729 | $388,738.27 | 2,015,494 | 2025-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.08 | 6,421 | $26,206.67 | 402,583 | 2025-05-20 | Filing | |
| $4.08 | 7,218 | $29,459.55 | 416,089 | 2025-05-20 | Filing | |
| $4.08 | 46,817 | $191,078.90 | 1,547,937 | 2025-05-20 | Filing | |
| $4.08 | 14,522 | $59,270.09 | 282,158 | 2025-05-20 | Filing | |
| $4.08 | 5,992 | $24,455.75 | 311,731 | 2025-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,747,853 | $81,331,585 | 0% | |
| 2. | 16,031,649 | $62,844,064 | 0% | |
| 3. | 15,057,940 | $59,066,043 | 0.03% | |
| 4. | 11,457,557 | $44,914,000 | 0.06% | |
| 5. | 9,841,871 | $38,580,134 | 0% |
News See All
Ardelyx, Inc. (NASDAQ:ARDX) Q2 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Ardelyx First Quarter 2025 Earnings Call.
Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX)
Ardelyx Inc. (NASDAQ:ARDX) is one of the best strong buy penny stocks to buy now. On July 28, Piper Sandler analyst Allison Bratzel maintained a Hold rating on Ardelyx Inc.
Ardelyx (ARDX) Rated as ‘Overweight’ at Cantor Fitzgerald amid Ibsrela Sales Growth Expectation
Ardelyx Inc. (NASDAQ:ARDX) is one of the penny stocks that will skyrocket. On July 7, analysts at Cantor Fitzgerald reiterated an ‘Overweight’ rating on the stock.
BTIG Remains a Buy on Ardelyx (ARDX) With a $14 PT
Ardelyx Inc. (NASDAQ:ARDX) is one of the best biotech penny stocks to buy right now. On July 29, BTIG analyst Julian Harrison maintained a Buy rating on Ardelyx Inc.
14 Best Biotech Penny Stocks to Buy Right Now
He acknowledged that biotech has been a “super tough sector” either way, as there are hundreds of publicly traded stocks that do not add up to anything in aggregate.
10 Penny Stocks That Will Skyrocket
Valuations in the equity markets sit at historical highs, raising questions about future market performance.
Ardelyx (ARDX) Announced New data for IBSRELA
Ardelyx, Inc. (NASDAQ:ARDX) is one of the Best American Penny Stocks to Buy According to Analysts. On May 6, Ardelyx, Inc.
11 Best American Penny Stocks to Buy According to Analysts
On July 19, Bailard released its Q2 2025 Small Cap Value Strategy report. The report highlights that in early April, fears of trade wars pushed the US equity markets near bear market territory.
Jefferies Maintains a Buy Rating on Ardelyx (ARDX) With an $8 Price Target
Ardelyx Inc. (NASDAQ:ARDX) is one of the 13 Stocks Under $5 With High Upside Potential. On July 2, Jefferies analyst Dennis Ding maintained a Buy rating on Ardelyx Inc.